Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
78 studies found for:    "Optic neuritis"
Show Display Options
RSS Create an RSS feed from your search for:
"Optic neuritis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: ACTHAR
2 Completed
Has Results
BIIB033 In Acute Optic Neuritis (AON)
Condition: Acute Optic Neuritis
Interventions: Biological: BIIB033 (anti-LINGO-1 mAb);   Drug: Placebo
3 Recruiting Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial
Condition: Optic Neuritis
Interventions: Drug: Erythropoietin alfa;   Drug: Placebo
4 Recruiting Lipoic Acid as a Treatment for Acute Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: Lipoic Acid
5 Terminated
Has Results
Fingolimod (FTY720) in Acute Demyelinating Optic Neuritis (ADON)
Condition: Acute Demylelinating Optic Neuritis
Interventions: Drug: Fingolimod 0.5mg/daily;   Drug: Placebo
6 Recruiting Optic Neuritis and Ganglion Cell Layer
Condition: Optic Neuritis
Intervention:
7 Completed Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: Erythropoietin
8 Recruiting Gypenosides Treatment for Optic Neuritis
Condition: Optic Neuritis
Interventions: Drug: Gypenosides;   Drug: Placebo
9 Completed Optic Neuritis Recovery After Oral or IV Corticosteroids
Condition: Optic Neuritis
Intervention: Drug: corticosteroids
10 Completed Interest of Dynamic Measures of the Pupil in Optic Neuritis
Condition: Optic Neuritis
Intervention: Other: measure of pupil diameter
11 Completed TLR-9 Antagonism in Steroid Resistant Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: Mycobacterium w.(Mw)-freeze dried extract 0.5ml
12 Terminated
Has Results
Atacicept in Subjects With Optic Neuritis
Condition: Optic Neuritis
Interventions: Drug: Atacicept;   Drug: Placebo matched to atacicept
13 Unknown  Effect of Vitamin D on Retinal Changes in Patient With Optic Neuritis by Optic Coherence Tomography
Condition: Optic Neuritis
Interventions: Drug: Vitamin D;   Drug: Vitamin D withheld
14 Recruiting Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
Condition: Optic Neuritis
Interventions: Drug: Clemastine;   Drug: Placebo
15 Recruiting Effect of Phenytoin on the Ganglion Cell Inner Plexiform Layer and Visual Field in Patients With an Acute Optic Neuritis
Condition: Optic Neuritis
Interventions: Drug: Phenytoin;   Drug: placebo
16 Completed
Has Results
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
Condition: Optic Neuritis
Interventions: Drug: Glatiramer Acetate;   Drug: placebo
17 Unknown  Simvastatin Treatment of Patients With Acute Optic Neuritis
Conditions: Optic Neuritis;   Multiple Sclerosis
Interventions: Drug: simvastatin;   Drug: placebo
18 Completed Visual Reconstitution Therapy After Optic Neuritis
Conditions: Optic Neuritis;   Multiple Sclerosis
Interventions: Other: Visual Reconstitutions Therapy;   Other: Saccadic Eye Movement Training
19 Completed Intravenous Immunoglobulin Therapy in Optic Neuritis
Condition: Optic Neuritis
Intervention: Drug: Immunoglobulin
20 Completed Ampyra for Optic Neuritis in MS
Conditions: Multiple Sclerosis;   Optic Neuritis
Interventions: Drug: Dalfampridine/Placebo;   Drug: Placebo/Dalfampridine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.